体外膜肺氧合作为流感引发的近乎致命性哮喘病例中成功进行综合治疗的桥梁和安全保障。
VV-ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza-triggered near-fatal asthma.
作者信息
Kowalewski Christoph, Schnürer Peter, Kopp Sabrina, Windschmitt Johannes, Oezkur Mehmet, Kriege Marc, Münzel Thomas, Kaes Joachim, Sagoschen Ingo, Wild Johannes
机构信息
Center for Cardiology, Cardiology I Johannes Gutenberg-University Mainz Mainz Germany.
Department of Cardiac and Vascular Surgery Johannes Gutenberg-University Mainz Mainz Germany.
出版信息
Clin Case Rep. 2023 Aug 10;11(8):e7709. doi: 10.1002/ccr3.7709. eCollection 2023 Aug.
KEY CLINICAL MESSAGE
In near-fatal asthma, the combination of ECMO therapy and isoflurane application via an intensive care ventilator with an anesthetic conservation device represents a therapeutic combination in seemingly hopeless clinical situations.
ABSTRACT
We report a case of an adult patient with near-fatal asthma, who was implanted venovenous extracorporeal membrane oxygenation in an extern hospital before transfer to our tertiary center. After 13 days and various therapeutic approaches, including inhaled isoflurane therapy via an anesthetic-conserving device, the patient was decannulated and extubated 3 days later.
关键临床信息
在近乎致命的哮喘中，体外膜肺氧合（ECMO）治疗与通过带有麻醉保存装置的重症监护呼吸机应用异氟烷的联合治疗，代表了在看似绝望的临床情况下的一种治疗组合。
摘要
我们报告了一例近乎致命哮喘的成年患者，该患者在转至我们的三级中心之前，在外院植入了静脉-静脉体外膜肺氧合。经过13天以及包括通过麻醉保存装置进行吸入异氟烷治疗在内的各种治疗方法后，患者拔管，3天后拔除ECMO导管。
Zotero 插件